Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Details

Stimulant Use Disorders: Developing Drugs for Treatment Guidance for Industry DRAFT GUIDANCE

FDA-2023-D-1848-0002Other
Document

Details

The document's own metadata, straight from the source system.

Title
Stimulant Use Disorders: Developing Drugs for Treatment Guidance for Industry DRAFT GUIDANCE
Posted
Oct 5, 2023
Agency
Food and Drug Administration (FDA)
View on regulations.gov ↗